Results for tag: "Rhinoconjunctivitis Drug"

The Rhinoconjunctivitis Drug market is a subset of the Allergy Drugs market, focusing on medications used to treat the symptoms of rhinoconjunctivitis, a condition characterized by inflammation of the nasal passages and eyes. These drugs are typically administered orally, intranasally, or topically, and can include antihistamines, decongestants, corticosteroids, and mast cell stabilizers. Commonly used to treat the symptoms of hay fever, rhinoconjunctivitis drugs can also be used to treat other allergic conditions such as asthma, eczema, and food allergies. The Rhinoconjunctivitis Drug market is highly competitive, with a range of generic and branded products available. Major players in the market include Sanofi, GlaxoSmithKline, Merck, Novartis, and Pfizer. Other companies in the market include Allergan, Boehringer Ingelheim, Cipla, Dr. Reddy's Laboratories, and Sun Pharmaceuticals. Show Less Read more